140 related articles for article (PubMed ID: 28132916)
1. Characterization of ligand binding to melanocortin 4 receptors using fluorescent peptides with improved kinetic properties.
Link R; Veiksina S; Rinken A; Kopanchuk S
Eur J Pharmacol; 2017 Mar; 799():58-66. PubMed ID: 28132916
[TBL] [Abstract][Full Text] [Related]
2. Budded baculoviruses as a tool for a homogeneous fluorescence anisotropy-based assay of ligand binding to G protein-coupled receptors: the case of melanocortin 4 receptors.
Veiksina S; Kopanchuk S; Rinken A
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):372-81. PubMed ID: 24095674
[TBL] [Abstract][Full Text] [Related]
3. Homogeneous fluorescence anisotropy-based assay for characterization of ligand binding dynamics to GPCRs in budded baculoviruses: the case of Cy3B-NDP-α-MSH binding to MC4 receptors.
Veiksina S; Kopanchuk S; Mazina O; Link R; Lille A; Rinken A
Methods Mol Biol; 2015; 1272():37-50. PubMed ID: 25563175
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence Anisotropy-Based Assay for Characterization of Ligand Binding Dynamics to GPCRs: The Case of Cy3B-Labeled Ligands Binding to MC
Veiksina S; Tahk MJ; Laasfeld T; Link R; Kopanchuk S; Rinken A
Methods Mol Biol; 2021; 2268():119-136. PubMed ID: 34085265
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence anisotropy assay for pharmacological characterization of ligand binding dynamics to melanocortin 4 receptors.
Veiksina S; Kopanchuk S; Rinken A
Anal Biochem; 2010 Jul; 402(1):32-9. PubMed ID: 20302839
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of time-resolved fluorescence probes for evaluation of competitive binding to melanocortin receptors.
Alleti R; Vagner J; Dehigaspitiya DC; Moberg VE; Elshan NG; Tafreshi NK; Brabez N; Weber CS; Lynch RM; Hruby VJ; Gillies RJ; Morse DL; Mash EA
Bioorg Med Chem; 2013 Sep; 21(17):5029-38. PubMed ID: 23890524
[TBL] [Abstract][Full Text] [Related]
7. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
8. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
[TBL] [Abstract][Full Text] [Related]
9. The constitutive activity of melanocortin-4 receptors in cAMP pathway is allosterically modulated by zinc and copper ions.
Link R; Veiksina S; Tahk MJ; Laasfeld T; Paiste P; Kopanchuk S; Rinken A
J Neurochem; 2020 May; 153(3):346-361. PubMed ID: 31792980
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of ligand binding to GPCR: Residence time of melanocortins and its modulation.
Rinken A; Veiksina S; Kopanchuk S
Pharmacol Res; 2016 Nov; 113(Pt B):747-753. PubMed ID: 27268144
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor.
Fernandes SM; Lee YS; Gillies RJ; Hruby VJ
Bioorg Med Chem; 2014 Nov; 22(22):6360-5. PubMed ID: 25438759
[TBL] [Abstract][Full Text] [Related]
12. Kinetic evidence for tandemly arranged ligand binding sites in melanocortin 4 receptor complexes.
Kopanchuk S; Veiksina S; Mutulis F; Mutule I; Yahorava S; Mandrika I; Petrovska R; Rinken A; Wikberg JE
Neurochem Int; 2006 Oct; 49(5):533-42. PubMed ID: 16764968
[TBL] [Abstract][Full Text] [Related]
13. Peptoid-peptide hybrids as potent novel melanocortin receptor ligands.
Kruijtzer JA; Nijenhuis WA; Wanders N; Gispen WH; Liskamp RM; Adan RA
J Med Chem; 2005 Jun; 48(13):4224-30. PubMed ID: 15974575
[TBL] [Abstract][Full Text] [Related]
14. Further evidence for ancient role of ACTH peptides at melanocortin (MC) receptors; pharmacology of dogfish and lamprey peptides at dogfish MC receptors.
Haitina T; Takahashi A; Holmén L; Enberg J; Schiöth HB
Peptides; 2007 Apr; 28(4):798-805. PubMed ID: 17306418
[TBL] [Abstract][Full Text] [Related]
15. Validation of flow cytometric competitive binding protocols and characterization of fluorescently labeled ligands.
Waller A; Pipkorn D; Sutton KL; Linderman JJ; Omann GM
Cytometry; 2001 Oct; 45(2):102-14. PubMed ID: 11590622
[TBL] [Abstract][Full Text] [Related]
16. Multimeric alpha-MSH has increased efficacy to activate the melanocortin MC4 receptor.
Tiesjema B; Merkestein M; Garner KM; de Krom M; Adan RA
Eur J Pharmacol; 2008 May; 585(1):24-30. PubMed ID: 18378226
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of two melanocortin (MC) receptors in lamprey showing orthology to the MC1 and MC4 receptor subtypes.
Haitina T; Klovins J; Takahashi A; Löwgren M; Ringholm A; Enberg J; Kawauchi H; Larson ET; Fredriksson R; Schiöth HB
BMC Evol Biol; 2007 Jun; 7():101. PubMed ID: 17603878
[TBL] [Abstract][Full Text] [Related]
18. Cloning, tissue distribution, pharmacology and three-dimensional modelling of melanocortin receptors 4 and 5 in rainbow trout suggest close evolutionary relationship of these subtypes.
Haitina T; Klovins J; Andersson J; Fredriksson R; Lagerström MC; Larhammar D; Larson ET; Schiöth HB
Biochem J; 2004 Jun; 380(Pt 2):475-86. PubMed ID: 14965341
[TBL] [Abstract][Full Text] [Related]
19. Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions.
Handl HL; Vagner J; Yamamura HI; Hruby VJ; Gillies RJ
Anal Biochem; 2004 Jul; 330(2):242-50. PubMed ID: 15203329
[TBL] [Abstract][Full Text] [Related]
20. Implementation of fluorescence anisotropy-based assay for the characterization of ligand binding to dopamine D
Allikalt A; Kopanchuk S; Rinken A
Eur J Pharmacol; 2018 Nov; 839():40-46. PubMed ID: 30205112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]